Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
12 Fevereiro 2025 - 6:35PM
Edgar (US Regulatory)
Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under
the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement
on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Cogent Biosciences, Inc.,
and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned
hereby execute this Agreement.
| Dated: | February 12, 2025 | |
| | | |
| Paradigm BioCapital Advisors LP | |
| Paradigm BioCapital Advisors GP LLC | |
| Paradigm BioCapital International Fund Ltd. | |
| | | |
| By: | /s/ David K. Kim | |
| Name: | David K. Kim | |
| Title: | Authorized Signatory | |
| | | |
| /s/ Senai Asefaw, M.D. | |
| Senai Asefaw, M.D. | |
Cogent Biosciences (NASDAQ:COGT)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Cogent Biosciences (NASDAQ:COGT)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
